menu
    • menu

    Company profile for Taiho Oncology

    NEW Drugs in Dev: 26
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Taiho Oncology is a different kind of pharmaceutical company. We have deep roots and unmatched corporate agility that enable us to fulfill our purpose – making a better world for cancer patients and the people who care for them. Our corporate philosophy is “We strive to improve human health & contribute to a society enriched by smiles.”For almost two decades, Taiho Oncology has served as a world-class clinical organizati...
    Taiho Oncology is a different kind of pharmaceutical company. We have deep roots and unmatched corporate agility that enable us to fulfill our purpose – making a better world for cancer patients and the people who care for them. Our corporate philosophy is “We strive to improve human health & contribute to a society enriched by smiles.”For almost two decades, Taiho Oncology has served as a world-class clinical organization, where people are at the center of everything we do. We work urgently to discover and develop innovative cancer treatments that address today’s unmet patient needs and apply the science behind them in novel ways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Taiho OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    101 Carnegie Center, Suite 101 Princeton, New Jersey 08540
    Telephone
    Telephone
    609-750-5300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.taihooncology.com/us/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Taiho Oncology Presents Azacitidine, Decitabine Data at ASH 2025
    Taiho Oncology Presents Azacitidine, Decitabine Data at ASH 2025

    08 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-presents-data-on-all-oral-regimens-azacitidine-and-cedazuridine-and-decitabine-and-cedazuridine-at-the-2025-american-society-of-hematology-annual-meeting-and-exposition-302634528.html

    PR NEWSWIRE
    08 Dec 2025
    Share Share
    Taiho Oncology Europe Launches Lytgobi For Cholangiocarcinoma
    Taiho Oncology Europe Launches Lytgobi For Cholangiocarcinoma

    03 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-03/taiho-oncology-europe-announces-the-launch-of-lytgobi-futibatinib-in-the-united-kingdom-for-elig

    PHARMIWEB
    03 Dec 2025
    Share Share
    Taiho, Cullinan Start NDA Submission For Zipalertinib In NSCLC
    Taiho, Cullinan Start NDA Submission For Zipalertinib In NSCLC

    20 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-taiho-pharmaceutical-and-cullinan-therapeutics-initiate-rolling-submission-of-new-drug-application-to-us-food-and-drug-administration-for-zipalertinib-for-treatment-of-locally-advanced-or-metastatic-non-small-cel-302621302.html

    PR NEWSWIRE
    20 Nov 2025
    Share Share
    Taiho Oncology to Share 14 Presentations at ASH 2025
    Taiho Oncology to Share 14 Presentations at ASH 2025

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-announces-14-presentations-including-six-oral-presentations-at-the-67th-american-society-of-hematology-annual-meeting-and-exposition-302613890.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    Taiho Oncology, Cullinan Therapeutics Present Zipalertinib Data
    Taiho Oncology, Cullinan Therapeutics Present Zipalertinib Data

    13 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-present-data-on-zipalertinib-in-patients-with-nsclc-with-egfr-mutations-and-active-brain-metastases-at-the-esmo-congress-2025-302581514.html

    PR NEWSWIRE
    13 Oct 2025
    Share Share
    Cullinan, Taiho's NSCLC Shows 'Strong Activity', Paves Way to FDA
    Cullinan, Taiho's NSCLC Shows 'Strong Activity', Paves Way to FDA

    10 Sep 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/cullinan-taihos-nsclc-hopeful-shows-strong-activity-clearing-road-to-fda

    BIOSPACE
    10 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search